30 results on '"Dumontet T"'
Search Results
2. L’excès de SUMOylation altère l’homéostasie postnatale du cortex surrénalien et conduit à un déficit isolé en glucocorticoïde
- Author
-
Dufour, D., primary, Dumontet, T., additional, Pussard, E., additional, Sahut-Barnola, I., additional, Lefrançois-Martinez, A.M., additional, Bossis, G., additional, Yeh, E.T., additional, Val, P., additional, and Martinez, A., additional
- Published
- 2021
- Full Text
- View/download PDF
3. La déSUMOylase SENP2 est nécessaire à la zonation fonctionnelle du cortex surrénalien
- Author
-
Dufour, D., primary, Dumontet, T., additional, Pussard, E., additional, Sahut-Barnola, I., additional, Lefrançois-Martinez, A.M., additional, Bossis, G., additional, Pointud, J.C., additional, Yeh, E.T.., additional, Val, P., additional, and Martinez, A., additional
- Published
- 2020
- Full Text
- View/download PDF
4. Rôle de EZH2 dans l’homéostasie du cortex surrénalien
- Author
-
Mathieu, M., primary, Tabbal, H., additional, Drelon, C., additional, Rodriguez, S., additional, Dumontet, T., additional, Sahut-Barnola, I., additional, Lefrancois-Martinez, A.M., additional, Martinez, A., additional, and Val, P., additional
- Published
- 2016
- Full Text
- View/download PDF
5. Molecular mechanisms regulated by the histone methyltransferase EZH2 in adrenocortical carcinoma
- Author
-
Tabbal, H., primary, Drelon, C., additional, Mathieu, M., additional, Rodriguez, S., additional, Batisse-Lignier, M., additional, Dumontet, T., additional, Sahut-Barnola, I., additional, Pointud, J.C., additional, Lefrançois-Martinez, A.M., additional, Giordano, T., additional, Ragazzon, B., additional, Bertherat, J., additional, Martinez, A., additional, and Val, P., additional
- Published
- 2016
- Full Text
- View/download PDF
6. Contribution du cortex fœtal à l’hyperplasie micronodulaire des surrénales : la PKA chef d’orchestre de la « partition » corticale ?
- Author
-
Sahut-Barnola, I., primary, Dumontet, T., additional, Lefrançois-Martinez, A.M., additional, Val, P., additional, and Martinez, A., additional
- Published
- 2016
- Full Text
- View/download PDF
7. Contrôle de la SUMOylation et zonation corticosurrénale
- Author
-
Dumontet, T., primary, Sahut-Barnola, I., additional, Ragazzon, B., additional, Rizk-Rabin, M., additional, Tissier, F., additional, Lefrançois-Martinez, A.M., additional, Bertherat, J., additional, Val, P., additional, and Martinez, A., additional
- Published
- 2016
- Full Text
- View/download PDF
8. Un modèle génétique murin pour l’exploration moléculaire et cellulaire des tumorigenèses testiculaires du complexe de Carney
- Author
-
Djari, C., primary, Barnola, I., additional, Dumontet, T., additional, Felicia, L., additional, Septier, A., additional, Val, P., additional, Martinez, A., additional, and Lefrançois-Martinez, A.-M., additional
- Published
- 2016
- Full Text
- View/download PDF
9. L’origine inattendue des dysplasies micronodulaires de la surrénale
- Author
-
Dumontet, T., primary, Sahut-Barnola, I., additional, Lefrancois-Martinez, A.M., additional, Pointud, J.C., additional, Morohashi, K.I., additional, Breault, D., additional, Val, P., additional, and Martinez, A., additional
- Published
- 2015
- Full Text
- View/download PDF
10. Signalisations et WNT et PKA dans la zonation et la tumorigenèse cortico-surrénalienne : cultiver l’antagonisme
- Author
-
Drelon, C., primary, Berthon, A., additional, Mathieu, M., additional, Dumontet, T., additional, Batisse-Lignier, M., additional, Tauveron, I., additional, Lefrançois-Martinez, A.M., additional, Vainio, S., additional, Schedl, A., additional, Stratakis, C., additional, Martinez, A., additional, and Val, P., additional
- Published
- 2015
- Full Text
- View/download PDF
11. Séquence de survenue des complications métaboliques du syndrome de Cushing et intérêt d’une approche anti-récepteur-GR : contribution d’un modèle génétique murin
- Author
-
Montanier, N., primary, Sahut-Barnola, I., additional, Pointud, J.C., additional, Wittrant, Y., additional, Rochefort, G., additional, Hunt, H., additional, Dumontet, T., additional, Lefrançois-Martinez, A.M., additional, Tauveron, I., additional, Val, P., additional, and Martinez, A., additional
- Published
- 2015
- Full Text
- View/download PDF
12. Signalisation PKA et SUMOylation : nouvelle hypothèse dans la physiopathologie des dysplasies micronodulaires de la surrénale
- Author
-
Dumontet, T., primary, Sahut-Barnola, I., additional, Ragazzon, B., additional, Rizk-Rabin, M., additional, Tissier, F., additional, Lefrançois-Martinez, A.-M., additional, Bertherat, J., additional, Val, P., additional, and Martinez, A., additional
- Published
- 2014
- Full Text
- View/download PDF
13. Dimorphisme sexuel dans l’hyperplasie micronodulaire des surrénales : plus de mâle c’est bien ?
- Author
-
Barnola, I. Sahut, primary, Dumontet, T., additional, Lefrançois-Martinez, A.M., additional, and Martinez, A., additional
- Published
- 2013
- Full Text
- View/download PDF
14. Non-canonical Wnt signaling triggered by WNT2B drives adrenal aldosterone production.
- Author
-
Borges KS, Little DW 3rd, Magalhães TA, Ribeiro C, Dumontet T, Lapensee C, Basham KJ, Seth A, Azova S, Guagliardo NA, Barrett PQ, Berber M, O'Connell AE, Turcu AF, Lerario AM, Mohan DR, Rainey W, Carlone DL, Hirschhorn JN, Salic A, Breault DT, and Hammer GD
- Abstract
The steroid hormone aldosterone, produced by the zona glomerulosa (zG) of the adrenal gland, is a master regulator of plasma electrolytes and blood pressure. While aldosterone control by the renin-angiotensin system is well understood, other key regulatory factors have remained elusive. Here, we replicated a prior association between a non-coding variant in WNT2B and an increased risk of primary aldosteronism, a prevalent and debilitating disease caused by excessive aldosterone production. We further show that in both mice and humans, WNT2B is expressed in the mesenchymal capsule surrounding the adrenal cortex, in close proximity to the zG. Global loss of Wnt2b in the mouse results in a dysmorphic and hypocellular zG, with impaired aldosterone production. Similarly, humans harboring WNT2B loss-of-function mutations develop a novel form of Familial Hyperreninemic Hypoaldosteronism, designated here as Type 4. Additionally, we demonstrate that WNT2B signals by activating the non-canonical Wnt/planar cell polarity pathway. Our findings identify WNT2B as a key regulator of zG function and aldosterone production with important clinical implications.
- Published
- 2024
- Full Text
- View/download PDF
15. Novel Candidate Regulators and Developmental Trajectory of Pituitary Thyrotropes.
- Author
-
Cheung LYM, Menage L, Rizzoti K, Hamilton G, Dumontet T, Basham K, Daly AZ, Brinkmeier ML, Masser BE, Treier M, Cobb J, Delogu A, Lovell-Badge R, Hammer GD, and Camper SA
- Subjects
- Pregnancy, Female, Mice, Animals, Thyrotropin metabolism, Pituitary Gland metabolism, Transcription Factors metabolism, Immunohistochemistry, SOXB2 Transcription Factors metabolism, Pituitary Diseases metabolism, Pituitary Gland, Anterior metabolism
- Abstract
The pituitary gland regulates growth, metabolism, reproduction, the stress response, uterine contractions, lactation, and water retention. It secretes hormones in response to hypothalamic input, end organ feedback, and diurnal cues. The mechanisms by which pituitary stem cells are recruited to proliferate, maintain quiescence, or differentiate into specific cell types, especially thyrotropes, are not well understood. We used single-cell RNA sequencing in juvenile P7 mouse pituitary cells to identify novel factors in pituitary cell populations, with a focus on thyrotropes and rare subtypes. We first observed cells coexpressing markers of both thyrotropes and gonadotropes, such as Pou1f1 and Nr5a1. This was validated in vivo by both immunohistochemistry and lineage tracing of thyrotropes derived from Nr5a1-Cre; mTmG mice and demonstrates that Nr5a1-progenitors give rise to a proportion of thyrotropes during development. Our data set also identifies novel factors expressed in pars distalis and pars tuberalis thyrotropes, including the Shox2b isoform in all thyrotropes and Sox14 specifically in Pou1f1-negative pars tuberalis thyrotropes. We have therefore used single-cell transcriptomics to determine a novel developmental trajectory for thyrotropes and potential novel regulators of thyrotrope populations., (© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
16. Loss of SUMO-specific protease 2 causes isolated glucocorticoid deficiency by blocking adrenal cortex zonal transdifferentiation in mice.
- Author
-
Dufour D, Dumontet T, Sahut-Barnola I, Carusi A, Onzon M, Pussard E, Wilmouth JJ, Olabe J, Lucas C, Levasseur A, Damon-Soubeyrand C, Pointud JC, Roucher-Boulez F, Tauveron I, Bossis G, Yeh ET, Breault DT, Val P, Lefrançois-Martinez AM, and Martinez A
- Subjects
- Animals, Mice, Adrenal Cortex metabolism, Adrenal Cortex Hormones metabolism, Adrenocorticotropic Hormone metabolism, beta Catenin metabolism, Wnt Signaling Pathway, Cell Transdifferentiation genetics, Cysteine Endopeptidases genetics, Cysteine Endopeptidases metabolism, Glucocorticoids metabolism
- Abstract
SUMOylation is a dynamic posttranslational modification, that provides fine-tuning of protein function involved in the cellular response to stress, differentiation, and tissue development. In the adrenal cortex, an emblematic endocrine organ that mediates adaptation to physiological demands, the SUMOylation gradient is inversely correlated with the gradient of cellular differentiation raising important questions about its role in functional zonation and the response to stress. Considering that SUMO-specific protease 2 (SENP2), a deSUMOylating enzyme, is upregulated by Adrenocorticotropic Hormone (ACTH)/cAMP-dependent Protein Kinase (PKA) signalling within the zona fasciculata, we generated mice with adrenal-specific Senp2 loss to address these questions. Disruption of SENP2 activity in steroidogenic cells leads to specific hypoplasia of the zona fasciculata, a blunted reponse to ACTH and isolated glucocorticoid deficiency. Mechanistically, overSUMOylation resulting from SENP2 loss shifts the balance between ACTH/PKA and WNT/β-catenin signalling leading to repression of PKA activity and ectopic activation of β-catenin. At the cellular level, this blocks transdifferentiation of β-catenin-positive zona glomerulosa cells into fasciculata cells and sensitises them to premature apoptosis. Our findings indicate that the SUMO pathway is critical for adrenal homeostasis and stress responsiveness., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
17. Gene expression changes in the brain of a Cushing's syndrome mouse model.
- Author
-
Amaya JM, Viho EMG, Sips HCM, Lalai RA, Sahut-Barnola I, Dumontet T, Montanier N, Pereira AM, Martinez A, and Meijer OC
- Subjects
- Animals, Brain metabolism, Gene Expression, Glucocorticoids metabolism, Humans, Mice, Receptors, Glucocorticoid genetics, Receptors, Glucocorticoid metabolism, Cushing Syndrome genetics, Cushing Syndrome metabolism
- Abstract
Excess glucocorticoid exposure affects emotional and cognitive brain functions. The extreme form, Cushing's syndrome, is adequately modelled in the AdKO
2.0 mouse, consequential to adrenocortical hypertrophy and hypercorticosteronemia. We previously reported that the AdKO2.0 mouse brain undergoes volumetric changes that resemble closely those of Cushing's syndrome human patients, as well as changes in expression of glial related marker proteins. In the present work, the expression of genes related to glial and neuronal cell populations and functions was assessed in regions of the anterior brain, hippocampus, amygdala and hypothalamus. Glucocorticoid target genes were consistently regulated, including CRH mRNA suppression in the hypothalamus and induction in amygdala and hippocampus, even if glucocorticoid receptor protein was downregulated. Expression of glial genes was also affected in the AdKO2.0 mouse brain, indicating a different activation status in glial cells. Generic markers for neuronal cell populations, and cellular integrity were only slightly affected. Our findings highlight the vulnerability of glial cell populations to chronic high levels of circulating glucocorticoids., (© 2022 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.)- Published
- 2022
- Full Text
- View/download PDF
18. Bones and adrenal organogenesis: how embryonic osteocalcin influences lifelong adrenal function.
- Author
-
Dumontet T and Hammer GD
- Subjects
- Animals, Glucocorticoids pharmacology, Osteocalcin genetics, Osteogenesis drug effects, Bone and Bones, Osteoblasts
- Abstract
Osteocalcin is a hormone produced in bones by osteoblasts during bone formation. Numerous studies have demonstrated that adrenal gland-derived glucocorticoids inhibit osteocalcin production, which can ultimately cause deleterious bones loss. This loss establishes a unidirectional endocrine relationship between the adrenal glands and bone, however, whether osteocalcin reciprocally regulates glucocorticoid secretion remains unclear. In this issue of the JCI, Yadav and colleagues address how bone-derived osteocalcin influences adrenal organogenesis and function. Using a large variety of animal models, the authors established that embryonic osteocalcin signaling, specifically through the GPR158 receptor, regulates postnatal adrenal steroid concentrations throughout life. This work has translational potential, and we await future investigations that determine whether modulating osteocalcin levels could promote endogenous adrenocortical function in adrenocortical hypoplasia and glucocorticoid deficiency.
- Published
- 2022
- Full Text
- View/download PDF
19. Adrenal androgens, adrenarche, and zona reticularis: A human affair?
- Author
-
Dumontet T and Martinez A
- Subjects
- Animals, Female, Gene Expression Profiling, Humans, Mice, Rats, Adrenarche metabolism, Androgens metabolism, Zona Reticularis metabolism
- Abstract
In humans, reticularis cells of the adrenal cortex fuel the production of androgen steroids, constituting the driver of numerous morphological changes during childhood. These steps are considered a precocious stage of sexual maturation and are grouped under the term "adrenarche". This review describes the molecular and enzymatic characteristics of the zona reticularis, along with the possible signals and mechanisms that control its emergence and the associated clinical features. We investigate the differences between species and discuss new studies such as genetic lineage tracing and transcriptomic analysis, highlighting the rodent inner cortex's cellular and molecular heterogeneity. The recent development and characterization of mouse models deficient for Prkar1a presenting with adrenocortical reticularis-like features prompt us to review our vision of the mouse adrenal gland maturation. We expect these new insights will help increase our understanding of the adrenarche process and the pathologies associated with its deregulation., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
20. β-catenin in adrenal zonation and disease.
- Author
-
Little DW 3rd, Dumontet T, LaPensee CR, and Hammer GD
- Subjects
- Animals, Humans, Ligands, Regeneration, Wnt Signaling Pathway, Adrenal Cortex metabolism, Adrenal Cortex pathology, Adrenal Gland Diseases metabolism, Adrenal Gland Diseases pathology, beta Catenin metabolism
- Abstract
The Wnt signaling pathway is a critical mediator of the development and maintenance of several tissues. The adrenal cortex is highly dependent upon Wnt/β-catenin signaling for proper zonation and endocrine function. Adrenocortical cells emerge in the peripheral capsule and subcapsular cortex of the gland as progenitor cells that centripetally differentiate into steroid hormone-producing cells of three functionally distinct concentric zones that respond robustly to various endocrine stimuli. Wnt/β-catenin signaling mediates adrenocortical progenitor cell fate and tissue renewal to maintain the gland throughout life. Aberrant Wnt/β-catenin signaling contributes to various adrenal disorders of steroid production and growth that range from hypofunction and hypoplasia to hyperfunction, hyperplasia, benign adrenocortical adenomas, and malignant adrenocortical carcinomas. Great strides have been made in defining the molecular underpinnings of adrenocortical homeostasis and disease, including the interplay between the capsule and cortex, critical components involved in maintaining the adrenocortical Wnt/β-catenin signaling gradient, and new targets in adrenal cancer. This review seeks to examine these and other recent advancements in understanding adrenocortical Wnt/β-catenin signaling and how this knowledge can inform therapeutic options for adrenal disease., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
21. Effects of Long-Term Endogenous Corticosteroid Exposure on Brain Volume and Glial Cells in the AdKO Mouse.
- Author
-
Amaya JM, Suidgeest E, Sahut-Barnola I, Dumontet T, Montanier N, Pagès G, Keller C, van der Weerd L, Pereira AM, Martinez A, and Meijer OC
- Abstract
Chronic exposure to high circulating levels of glucocorticoids has detrimental effects on health, including metabolic abnormalities, as exemplified in Cushing's syndrome (CS). Magnetic resonance imaging (MRI) studies have found volumetric changes in gray and white matter of the brain in CS patients during the course of active disease, but also in remission. In order to explore this further, we performed MRI-based brain volumetric analyses in the AdKO mouse model for CS, which presents its key traits. AdKO mice had reduced relative volumes in several brain regions, including the corpus callosum and cortical areas. The medial amygdala, bed nucleus of the stria terminalis, and hypothalamus were increased in relative volume. Furthermore, we found a lower immunoreactivity of myelin basic protein (MBP, an oligodendrocyte marker) in several brain regions but a paradoxically increased MBP signal in the male cingulate cortex. We also observed a decrease in the expression of glial fibrillary acidic protein (GFAP, a marker for reactive astrocytes) and ionized calcium-binding adapter molecule 1 (IBA1, a marker for activated microglia) in the cingulate regions of the anterior corpus callosum and the hippocampus. We conclude that long-term hypercorticosteronemia induced brain region-specific changes that might include aberrant myelination and a degree of white matter damage, as both repair (GFAP) and immune (IBA1) responses are decreased. These findings suggest a cause for the changes observed in the brains of human patients and serve as a background for further exploration of their subcellular and molecular mechanisms., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Amaya, Suidgeest, Sahut-Barnola, Dumontet, Montanier, Pagès, Keller, van der Weerd, Pereira, Martinez and Meijer.)
- Published
- 2021
- Full Text
- View/download PDF
22. Hormonal and spatial control of SUMOylation in the human and mouse adrenal cortex.
- Author
-
Dumontet T, Sahut-Barnola I, Dufour D, Lefrançois-Martinez AM, Berthon A, Montanier N, Ragazzon B, Djari C, Pointud JC, Roucher-Boulez F, Batisse-Lignier M, Tauveron I, Bertherat J, Val P, and Martinez A
- Subjects
- Adrenal Cortex drug effects, Adrenal Cortex ultrastructure, Adrenal Cortex Neoplasms pathology, Adrenocorticotropic Hormone administration & dosage, Animals, Carney Complex metabolism, Cell Line, Tumor, Colforsin pharmacology, Cyclic AMP-Dependent Protein Kinases physiology, Cycloheximide pharmacology, Dactinomycin pharmacology, Delayed-Action Preparations, Dexamethasone analogs & derivatives, Dexamethasone pharmacology, Female, Humans, Mice, Mice, Knockout, Mice, Transgenic, Neoplasm Proteins metabolism, Protein Processing, Post-Translational drug effects, Signal Transduction drug effects, Sumoylation drug effects, Wnt Signaling Pathway drug effects, Wnt Signaling Pathway physiology, Zona Fasciculata drug effects, Zona Fasciculata metabolism, Zona Glomerulosa drug effects, Zona Glomerulosa metabolism, beta Catenin deficiency, beta Catenin genetics, Adrenal Cortex metabolism, Adrenocorticotropic Hormone pharmacology, Protein Processing, Post-Translational physiology, Sumoylation physiology
- Abstract
SUMOylation is a highly conserved and dynamic post-translational mechanism primarily affecting nuclear programs for adapting organisms to stressful challenges. Alteration of SUMOylation cycles leads to severe developmental and homeostatic defects and malignancy, but signals coordinating SUMOylation are still unidentified. The adrenal cortex is a zonated endocrine gland that controls body homeostasis and stress response. Here, we show that in human and in mouse adrenals, SUMOylation follows a decreasing centripetal gradient that mirrors cortical differentiation flow and delimits highly and weakly SUMOylated steroidogenic compartments, overlapping glomerulosa, and fasciculata zones. Activation of PKA signaling by acute hormonal treatment, mouse genetic engineering, or in Carney complex results in repression of small ubiquitin-like modifier (SUMO) conjugation in the inner cortex by coordinating expression of SUMO pathway inducers and repressors. Conversely, genetic activation of canonical wingless-related integration site signaling maintains high SUMOylation potential in the outer neoplastic cortex. Thus, SUMOylation is tightly regulated by signaling pathways that orchestrate adrenal zonation and diseases.-Dumontet, T., Sahut-Barnola, I., Dufour, D., Lefrançois-Martinez, A.-M., Berthon, A., Montanier, N., Ragazzon, B., Djari, C., Pointud, J.-C., Roucher-Boulez, F., Batisse-Lignier, M., Tauveron, I., Bertherat, J., Val, P., Martinez, A. Hormonal and spatial control of SUMOylation in the human and mouse adrenal cortex.
- Published
- 2019
- Full Text
- View/download PDF
23. Steroidogenic differentiation and PKA signaling are programmed by histone methyltransferase EZH2 in the adrenal cortex.
- Author
-
Mathieu M, Drelon C, Rodriguez S, Tabbal H, Septier A, Damon-Soubeyrand C, Dumontet T, Berthon A, Sahut-Barnola I, Djari C, Batisse-Lignier M, Pointud JC, Richard D, Kerdivel G, Calméjane MA, Boeva V, Tauveron I, Lefrançois-Martinez AM, Martinez A, and Val P
- Subjects
- Adrenal Cortex metabolism, Animals, Cell Differentiation, Cyclic AMP-Dependent Protein Kinase RIbeta Subunit genetics, Cyclic Nucleotide Phosphodiesterases, Type 1 genetics, Cyclic Nucleotide Phosphodiesterases, Type 1 metabolism, Cyclic Nucleotide Phosphodiesterases, Type 3 genetics, Cyclic Nucleotide Phosphodiesterases, Type 3 metabolism, Cyclic Nucleotide Phosphodiesterases, Type 7 genetics, Cyclic Nucleotide Phosphodiesterases, Type 7 metabolism, Enhancer of Zeste Homolog 2 Protein genetics, Female, Male, Mice, Inbred C57BL, Mice, Knockout, Steroids metabolism, Zona Fasciculata cytology, Zona Fasciculata enzymology, Zona Fasciculata metabolism, Zona Glomerulosa cytology, Zona Glomerulosa enzymology, Zona Glomerulosa metabolism, Adrenal Cortex enzymology, Cyclic AMP-Dependent Protein Kinase RIbeta Subunit metabolism, Enhancer of Zeste Homolog 2 Protein metabolism, Signal Transduction
- Abstract
Adrenal cortex steroids are essential for body homeostasis, and adrenal insufficiency is a life-threatening condition. Adrenal endocrine activity is maintained through recruitment of subcapsular progenitor cells that follow a unidirectional differentiation path from zona glomerulosa to zona fasciculata (zF). Here, we show that this unidirectionality is ensured by the histone methyltransferase EZH2. Indeed, we demonstrate that EZH2 maintains adrenal steroidogenic cell differentiation by preventing expression of GATA4 and WT1 that cause abnormal dedifferentiation to a progenitor-like state in Ezh2 KO adrenals. EZH2 further ensures normal cortical differentiation by programming cells for optimal response to adrenocorticotrophic hormone (ACTH)/PKA signaling. This is achieved by repression of phosphodiesterases PDE1B, 3A, and 7A and of PRKAR1B. Consequently, EZH2 ablation results in blunted zF differentiation and primary glucocorticoid insufficiency. These data demonstrate an all-encompassing role for EZH2 in programming steroidogenic cells for optimal response to differentiation signals and in maintaining their differentiated state., Competing Interests: The authors declare no conflict of interest.
- Published
- 2018
- Full Text
- View/download PDF
24. Adrenocortical development: Lessons from mouse models.
- Author
-
Dumontet T, Sahut-Barnola I, Septier A, Montanier N, Plotton I, Roucher-Boulez F, Ducros V, Lefrançois-Martinez AM, Pointud JC, Zubair M, Morohashi KI, Breault DT, Val P, and Martinez A
- Subjects
- Adrenal Glands embryology, Adrenal Glands growth & development, Animals, Cell Differentiation, Female, Humans, Male, Mice, Knockout, Sexual Maturation physiology, Adrenal Cortex embryology, Adrenal Cortex growth & development, Mice, Models, Animal
- Abstract
The adrenocortical gland undergoes structural and functional remodelling in the fetal and postnatal periods. After birth, the fetal zone of the gland undergoes rapid involution in favor of the definitive cortex, which reaches maturity with the emergence of the zona reticularis(zR) at the adrenarche. The mechanisms underlying the adrenarche, the process leading to pre-puberty elevation of plasma androgens in higher primates, remain unknown, largely due to lack of any experimental model. By following up fetal and definitive cortex cell lines in mice, we showed that activation of protein kinase A (PKA) signaling mainly impacts the adult cortex by stimulating centripetal regeneration, with differentiation and then conversion of the zona fasciculata into a functional zR. Animals developed Cushing syndrome associated with primary hyperaldosteronism, suggesting possible coexistence of these hypersecretions in certain patients. Remarkably, all of these traits were sex-dependent: testicular androgens promoted WNT signaling antagonism on PKA, slowing cortical renewal and delaying onset of Cushing syndrome and the establishment of the zR in male mice, this being corrected by orchidectomy. In conclusion, zR derives from centripetal conversion of the zona fasciculata under cellular renewal induced by PKA signaling, determining the size of the adult cortex. Finally, we demonstrated that this PKA-dependent mobilization of cortical progenitors is sexually dimorphic and could, if confirmed in humans, account for female preponderance in adrenocortical pathologies., (Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
25. PKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal.
- Author
-
Dumontet T, Sahut-Barnola I, Septier A, Montanier N, Plotton I, Roucher-Boulez F, Ducros V, Lefrançois-Martinez AM, Pointud JC, Zubair M, Morohashi KI, Breault DT, Val P, and Martinez A
- Subjects
- Adrenarche metabolism, Age Factors, Androgens metabolism, Animals, Cell Differentiation physiology, Cyclic AMP-Dependent Protein Kinase RIalpha Subunit genetics, Embryo, Mammalian, Female, Male, Mice, Mice, Knockout, Models, Animal, Cyclic AMP-Dependent Protein Kinase RIalpha Subunit metabolism, Sex Characteristics, Signal Transduction physiology, Zona Fasciculata metabolism, Zona Reticularis metabolism
- Abstract
The adrenal cortex undergoes remodeling during fetal and postnatal life. How zona reticularis emerges in the postnatal gland to support adrenarche, a process whereby higher primates increase prepubertal androgen secretion, is unknown. Using cell-fate mapping and gene deletion studies in mice, we show that activation of PKA has no effect on the fetal cortex, while it accelerates regeneration of the adult cortex, triggers zona fasciculata differentiation that is subsequently converted into a functional reticularis-like zone, and drives hypersecretion syndromes. Remarkably, PKA effects are influenced by sex. Indeed, testicular androgens increase WNT signaling that antagonizes PKA, leading to slower adrenocortical cell turnover and delayed phenotype whereas gonadectomy sensitizes males to hypercorticism and reticularis-like formation. Thus, reticularis results from ultimate centripetal conversion of adult cortex under the combined effects of PKA and cell turnover that dictate organ size. We show that PKA-induced progenitor recruitment is sexually dimorphic and may provide a paradigm for overrepresentation of women in adrenal diseases.
- Published
- 2018
- Full Text
- View/download PDF
26. PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development.
- Author
-
Drelon C, Berthon A, Sahut-Barnola I, Mathieu M, Dumontet T, Rodriguez S, Batisse-Lignier M, Tabbal H, Tauveron I, Lefrançois-Martinez AM, Pointud JC, Gomez-Sanchez CE, Vainio S, Shan J, Sacco S, Schedl A, Stratakis CA, Martinez A, and Val P
- Subjects
- Animals, Carcinogenesis, Cell Differentiation, Cell Line, Tumor, Female, Humans, Mice, Phosphorylation, Zona Fasciculata cytology, Zona Glomerulosa cytology, beta Catenin metabolism, Adrenal Gland Neoplasms etiology, Cyclic AMP-Dependent Protein Kinases metabolism, Wnt Signaling Pathway, Zona Fasciculata metabolism, Zona Glomerulosa metabolism
- Abstract
Adrenal cortex physiology relies on functional zonation, essential for production of aldosterone by outer zona glomerulosa (ZG) and glucocorticoids by inner zona fasciculata (ZF). The cortex undergoes constant cell renewal, involving recruitment of subcapsular progenitors to ZG fate and subsequent lineage conversion to ZF identity. Here we show that WNT4 is an important driver of WNT pathway activation and subsequent ZG differentiation and demonstrate that PKA activation prevents ZG differentiation through WNT4 repression and WNT pathway inhibition. This suggests that PKA activation in ZF is a key driver of WNT inhibition and lineage conversion. Furthermore, we provide evidence that constitutive PKA activation inhibits, whereas partial inactivation of PKA catalytic activity stimulates β-catenin-induced tumorigenesis. Together, both lower PKA activity and higher WNT pathway activity lead to poorer prognosis in adrenocortical carcinoma (ACC) patients. These observations suggest that PKA acts as a tumour suppressor in the adrenal cortex, through repression of WNT signalling.
- Published
- 2016
- Full Text
- View/download PDF
27. EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression.
- Author
-
Drelon C, Berthon A, Mathieu M, Ragazzon B, Kuick R, Tabbal H, Septier A, Rodriguez S, Batisse-Lignier M, Sahut-Barnola I, Dumontet T, Pointud JC, Lefrançois-Martinez AM, Baron S, Giordano TJ, Bertherat J, Martinez A, and Val P
- Subjects
- Adrenal Cortex Neoplasms metabolism, Animals, Cell Line, Tumor, Cell Proliferation, Databases, Nucleic Acid, Disease Progression, Gene Expression, Genetic Predisposition to Disease genetics, Humans, Insulin-Like Growth Factor II genetics, Insulin-Like Growth Factor II metabolism, Mice, Mice, Transgenic, RNA Interference, Risk Factors, Wnt Signaling Pathway, beta Catenin genetics, Adrenal Cortex Neoplasms genetics, Enhancer of Zeste Homolog 2 Protein genetics, Enhancer of Zeste Homolog 2 Protein metabolism
- Abstract
Adrenal Cortex Carcinoma (ACC) is an aggressive tumour with poor prognosis. Common alterations in patients include constitutive WNT/β-catenin signalling and overexpression of the growth factor IGF2. However, the combination of both alterations in transgenic mice is not sufficient to trigger malignant tumour progression, suggesting that other alterations are required to allow development of carcinomas. Here, we have conducted a study of publicly available gene expression data from three cohorts of ACC patients to identify relevant alterations. Our data show that the histone methyltransferase EZH2 is overexpressed in ACC in the three cohorts. This overexpression is the result of deregulated P53/RB/E2F pathway activity and is associated with increased proliferation and poorer prognosis in patients. Inhibition of EZH2 by RNA interference or pharmacological treatment with DZNep inhibits cellular growth, wound healing and clonogenic growth and induces apoptosis of H295R cells in culture. Further growth inhibition is obtained when DZNep is combined with mitotane, the gold-standard treatment for ACC. Altogether, these observations suggest that overexpression of EZH2 is associated with aggressive progression and may constitute an interesting therapeutic target in the context of ACC., (© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
28. The adrenal capsule is a signaling center controlling cell renewal and zonation through Rspo3.
- Author
-
Vidal V, Sacco S, Rocha AS, da Silva F, Panzolini C, Dumontet T, Doan TM, Shan J, Rak-Raszewska A, Bird T, Vainio S, Martinez A, and Schedl A
- Subjects
- Adrenal Cortex cytology, Animals, Cell Proliferation, Embryo, Mammalian, Gene Deletion, Gene Expression Regulation, Developmental genetics, Homeostasis genetics, Male, Mice, Thrombospondins genetics, Zona Glomerulosa cytology, Zona Glomerulosa metabolism, beta Catenin metabolism, Adrenal Cortex physiology, Cell Differentiation genetics, Signal Transduction genetics, Thrombospondins metabolism
- Abstract
Adrenal glands are zonated endocrine organs that are essential in controlling body homeostasis. How zonation is induced and maintained and how renewal of the adrenal cortex is ensured remain a mystery. Here we show that capsular RSPO3 signals to the underlying steroidogenic compartment to induce β-catenin signaling and imprint glomerulosa cell fate. Deletion of RSPO3 leads to loss of SHH signaling and impaired organ growth. Importantly, Rspo3 function remains essential in adult life to ensure replenishment of lost cells and maintain the properties of the zona glomerulosa. Thus, the adrenal capsule acts as a central signaling center that ensures replacement of damaged cells and is required to maintain zonation throughout life., (© 2016 Vidal et al.; Published by Cold Spring Harbor Laboratory Press.)
- Published
- 2016
- Full Text
- View/download PDF
29. LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis.
- Author
-
Just PA, Poncy A, Charawi S, Dahmani R, Traore M, Dumontet T, Drouet V, Dumont F, Gilgenkrantz H, Colnot S, Terris B, Coulouarn C, Lemaigre F, and Perret C
- Subjects
- AMP-Activated Protein Kinase Kinases, AMP-Activated Protein Kinases, Animals, Bile Duct Neoplasms metabolism, Bile Duct Neoplasms pathology, Bile Ducts metabolism, Cell Line, Tumor, Cholangiocarcinoma metabolism, Cholangiocarcinoma pathology, Cholestasis genetics, Cholestasis pathology, Humans, Immunoglobulin J Recombination Signal Sequence-Binding Protein genetics, Immunoglobulin J Recombination Signal Sequence-Binding Protein metabolism, Liver embryology, Mice, Transgenic, Morphogenesis, Protein Serine-Threonine Kinases genetics, Receptors, Notch genetics, Bile Ducts embryology, Protein Serine-Threonine Kinases metabolism, Receptors, Notch metabolism
- Abstract
Background: LKB1 is an evolutionary conserved kinase implicated in a wide range of cellular functions including inhibition of cell proliferation, regulation of cell polarity and metabolism. When Lkb1 is inactivated in the liver, glucose homeostasis is perturbed, cellular polarity is affected and cholestasis develops. Cholestasis occurs as a result from deficient bile duct development, yet how LKB1 impacts on biliary morphogenesis is unknown., Methodology/principal Findings: We characterized the phenotype of mice in which deletion of the Lkb1 gene has been specifically targeted to the hepatoblasts. Our results confirmed that lack of LKB1 in the liver results in bile duct paucity leading to cholestasis. Immunostaining analysis at a prenatal stage showed that LKB1 is not required for differentiation of hepatoblasts to cholangiocyte precursors but promotes maturation of the primitive ductal structures to mature bile ducts. This phenotype is similar to that obtained upon inactivation of Notch signaling in the liver. We tested the hypothesis of a functional overlap between the LKB1 and Notch pathways by gene expression profiling of livers deficient in Lkb1 or in the Notch mediator RbpJκ and identified a mutual cross-talk between LKB1 and Notch signaling. In vitro experiments confirmed that Notch activity was deficient upon LKB1 loss., Conclusion: LKB1 and Notch share a common genetic program in the liver, and regulate bile duct morphogenesis.
- Published
- 2015
- Full Text
- View/download PDF
30. mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD).
- Author
-
de Joussineau C, Sahut-Barnola I, Tissier F, Dumontet T, Drelon C, Batisse-Lignier M, Tauveron I, Pointud JC, Lefrançois-Martinez AM, Stratakis CA, Bertherat J, Val P, and Martinez A
- Subjects
- Adrenal Cortex Diseases genetics, Adrenocorticotropic Hormone administration & dosage, Adrenocorticotropic Hormone pharmacology, Animals, Apoptosis drug effects, Cell Line, Tumor, Cyclic AMP-Dependent Protein Kinase RIalpha Subunit metabolism, Disease Models, Animal, Gene Knockout Techniques, Humans, Male, Mechanistic Target of Rapamycin Complex 1, Mice, Multiprotein Complexes metabolism, Phosphorylation, Signal Transduction drug effects, Sirolimus pharmacology, TOR Serine-Threonine Kinases metabolism, Adrenal Cortex Diseases metabolism, Adrenal Cortex Diseases pathology, Cyclic AMP-Dependent Protein Kinase RIalpha Subunit genetics, bcl-Associated Death Protein metabolism
- Abstract
Primary pigmented nodular adrenocortical disease (PPNAD) is associated with inactivating mutations of the PRKAR1A tumor suppressor gene that encodes the regulatory subunit R1α of the cAMP-dependent protein kinase (PKA). In human and mouse adrenocortical cells, these mutations lead to increased PKA activity, which results in increased resistance to apoptosis that contributes to the tumorigenic process. We used in vitro and in vivo models to investigate the possibility of a crosstalk between PKA and mammalian target of rapamycin (mTOR) pathways in adrenocortical cells and its possible involvement in apoptosis resistance. Impact of PKA signaling on activation of the mTOR pathway and apoptosis was measured in a mouse model of PPNAD (AdKO mice), in human and mouse adrenocortical cell lines in response to pharmacological inhibitors and in PPNAD tissues by immunohistochemistry. AdKO mice showed increased mTOR complex 1 (mTORC1) pathway activity. Inhibition of mTORC1 by rapamycin restored sensitivity of adrenocortical cells to apoptosis in AdKO but not in wild-type mice. In both cell lines and mouse adrenals, rapid phosphorylation of mTORC1 targets including BAD proapoptotic protein was observed in response to PKA activation. Accordingly, BAD hyperphosphorylation, which inhibits its proapoptotic activity, was increased in both AdKO mouse adrenals and human PPNAD tissues. In conclusion, mTORC1 pathway is activated by PKA signaling in human and mouse adrenocortical cells, leading to increased cell survival, which is correlated with BAD hyperphosphorylation. These alterations could be causative of tumor formation., (© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.